Intranasal Botulinum Toxin A for Gustatory and Vasomotor Rhinitis: A Randomized Controlled Trial Comparing Injection and Spray Delivery

Background: Gustatory and vasomotor rhinitis (non-allergic rhinitis, NAR) are disabling conditions driven by neural dysregulation and glandular hypersecretion. Botulinum toxin A (BoNT-A) has emerged as an off-label treatment, but optimal delivery modalities remain undefined. Methods: We conducted a prospective, randomized, triple-blind, placebo-controlled trial. Ninety adults with gustatory or vasomotor rhinitis were randomized 1:1:1 to receive BoNT-A via submucosal injection (n=30), topical spray (n=30), or placebo control (n=30). The primary outcome was the change in composite Visual Analog Scale (VAS) scores at 12 weeks. Secondary outcomes included individual symptom scores, responder rates, and adverse events. Results: Baseline characteristics were comparable across all groups. At 12 weeks, BoNT-A injection yielded the greatest improvement in composite VAS scores, significantly outperforming both the spray and control groups (p<0.001). The spray group also showed significant improvement over the control (p<0.05), but with a significantly smaller effect size than the injection group (p=0.03). Injection delivery was particularly superior for rhinorrhea-dominant phenotypes. Adverse events were mild and transient. Conclusion: Intranasal BoNT-A is highly effective for NAR, but submucosal injection provides superior efficacy compared to topical spray administration. Both modalities are safe and offer a valuable minimally invasive option for refractory cases.

Authors

Publication Details

Journal
Figshare
Published
2026-11-21
DOI
https://doi.org/10.6084/m9.figshare.35082247
Primary Topic
Allergic Rhinitis and Sensitization
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Intranasal Botulinum Toxin A for Gustatory and Vasomotor Rhinitis: A Randomized Controlled Trial Comparing Injection and Spray Delivery

Hany Amin Riad
Figshare
Allergic Rhinitis and Sensitization
preprint

Intranasal Botulinum Toxin A for Gustatory and Vasomotor Rhinitis: A Randomized Controlled Trial Comparing Injection and Spray Delivery

Hany Amin Riad
preprint en

Abstract

Background: Gustatory and vasomotor rhinitis (non-allergic rhinitis, NAR) are disabling conditions driven by neural dysregulation and glandular hypersecretion. Botulinum toxin A (BoNT-A) has emerged as an off-label treatment, but optimal delivery modalities remain undefined. Methods: We conducted a prospective, randomized, triple-blind, placebo-controlled trial. Ninety adults with gustatory or vasomotor rhinitis were randomized 1:1:1 to receive BoNT-A via submucosal injection (n=30), topical spray (n=30), or placebo control (n=30). The primary outcome was the change in composite Visual Analog Scale (VAS) scores at 12 weeks. Secondary outcomes included individual symptom scores, responder rates, and adverse events. Results: Baseline characteristics were comparable across all groups. At 12 weeks, BoNT-A injection yielded the greatest improvement in composite VAS scores, significantly outperforming both the spray and control groups (p<0.001). The spray group also showed significant improvement over the control (p<0.05), but with a significantly smaller effect size than the injection group (p=0.03). Injection delivery was particularly superior for rhinorrhea-dominant phenotypes. Adverse events were mild and transient. Conclusion: Intranasal BoNT-A is highly effective for NAR, but submucosal injection provides superior efficacy compared to topical spray administration. Both modalities are safe and offer a valuable minimally invasive option for refractory cases.

Figshare
Allergic Rhinitis and Sensitization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Intranasal Botulinum Toxin A for Gustatory and Vasomotor Rhinitis: A Randomized Controlled Trial Comparing Injection and Spray Delivery — Hany Amin Riad · Figshare (2026) | TGRS Research Map | TGRS